Edition:
United States

GenMark Diagnostics Inc (GNMK.OQ)

GNMK.OQ on NASDAQ Stock Exchange Global Market

4.81USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
88,689
52-wk High
$8.81
52-wk Low
$3.98

Latest Key Developments (Source: Significant Developments)

Casdin Capital Reports 7 Pct Stake In Genmark Diagnostics
Tuesday, 27 Mar 2018 03:55pm EDT 

March 27 (Reuters) - Genmark Diagnostics Inc ::CASDIN CAPITAL REPORTS A 7 PERCENT STAKE IN GENMARK DIAGNOSTICS AS OF MARCH 20 - SEC FILING.  Full Article

Genmark Diagnostics Q4 Loss Per Share $0.26
Tuesday, 27 Feb 2018 04:03pm EST 

Feb 27 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 LOSS PER SHARE $0.26.Q4 REVENUE ROSE 8 PERCENT TO $16 MILLION.SEES FY 2018 REVENUE $68 MILLION TO $72 MILLION.Q4 EARNINGS PER SHARE VIEW $-0.26, REVENUE VIEW $15.6 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $69.5 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

GenMark Diagnostics Sees Q4 2017 Revenue About $16 Mln
Tuesday, 9 Jan 2018 07:05am EST 

Jan 9 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS PROVIDES PRELIMINARY OPERATIONAL AND FINANCIAL RESULTS FOR 2017.SEES FY 2017 REVENUE ABOUT $52.5 MILLION.SEES Q4 2017 REVENUE ABOUT $16 MILLION.SEES FY 2017 REVENUE UP 7 PERCENT.SEES Q4 2017 REVENUE UP 8 PERCENT.Q4 REVENUE VIEW $15.2 MILLION -- THOMSON REUTERS I/B/E/S.FY2017 REVENUE VIEW $51.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Genmark Diagnostics Entered Fifth Amendment To Loan And Security Agreement
Thursday, 14 Dec 2017 04:36pm EST 

Dec 14 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS INC - ON DEC 13 CO ENTERED FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT WITH SOLAR SENIOR CAPITAL - SEC FILING.GENMARK DIAGNOSTICS INC - AS PER AMENDMENT, MATURITY DATE FOR LOAN AND SECURITY AGREEMENT EXTENDED TO MARCH 12, 2020.  Full Article

Genmark Diagnostics Q3 loss per share $0.28
Thursday, 2 Nov 2017 04:05pm EDT 

Nov 2 (Reuters) - Genmark Diagnostics Inc :Genmark diagnostics reports third quarter 2017 results.Q3 loss per share $0.28.Q3 revenue rose 7.3 percent to $11.6 million.Q3 revenue view $14.6 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue $51 million to $53 million.  Full Article

Genmark Diagnostics Q2 earnings per share view $0.32
Tuesday, 1 Aug 2017 08:05am EDT 

Aug 1 (Reuters) - Genmark Diagnostics Inc :Genmark reports second quarter 2017 results.Q2 loss per share $0.37.Q2 revenue $12.4 million versus I/B/E/S view $12.4 million.Q2 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.Genmark Diagnostics Inc - ‍company ended quarter with $106.5 million in cash and cash equivalents​.  Full Article

GenMark diagnostics commences public offering of common stock
Monday, 12 Jun 2017 04:01pm EDT 

June 12 (Reuters) - Genmark Diagnostics Inc ::Genmark Diagnostics commences public offering of common stock.Genmark Diagnostics Inc - commenced an underwritten public offering of $65 million of shares of its common stock.J.P. Morgan and BofA Merrill lynch are acting as joint book-running managers for offering.Intends to grant underwriters a 30-day option to purchase up to $9.75 million of additional shares.  Full Article

Genmark receives FDA 510(k) market clearance for its Eplex instrument and respiratory pathogen panel
Monday, 12 Jun 2017 08:05am EDT 

June 12 (Reuters) - Genmark Diagnostics Inc :Genmark receives FDA 510(k) market clearance for its eplex® instrument and respiratory pathogen panel.Says expects q2 2017 revenues in range of $12 to $13 million.Says for full year 2017, co continues to expect revenue in range of $65 to $70 million.Genmark diagnostics says it intends to draw down an additional $15 million under terms of its existing debt facility.Genmark diagnostics - revenue from eplex installations at u.s. Customer sites expected to positively impact second half of 2017.Fy2017 revenue view $67.3 million -- Thomson Reuters I/B/E/S.Q2 revenue view $13.8 million -- Thomson Reuters I/B/E/S.  Full Article

Genmark Diagnostics reports Q1 revenue $12.5 million
Tuesday, 2 May 2017 04:05pm EDT 

May 2 (Reuters) - Genmark Diagnostics Inc :Genmark Diagnostics reports first quarter 2017 results.Q1 revenue $12.5 million versus I/B/E/S view $12.5 million.Q1 loss per share $0.30.Sees FY 2017 revenue $65 million to $70 million.Q1 earnings per share view $-0.28 -- Thomson Reuters I/B/E/S.Genmark Diagnostics Inc - For full year 2017, company continues to expect revenue in range of $65 to $70 million and gross margin in range of 48-52%..  Full Article

Genmark Diagnostics Q1 preliminary revenue $12.5 mln
Thursday, 20 Apr 2017 06:58pm EDT 

April 20 (Reuters) - Genmark Diagnostics Inc :Genmark achieves ce mark for its eplex® blood culture identification fungal pathogen panel.reports positive preliminary q1 revenues of $12.5 million up 13% versus prior year.during q1, it added more than 15 customer agreements.Q1 revenue view $12.5 million -- Thomson Reuters I/B/E/S.  Full Article